Previous Close | 0.2250 |
Open | 0.2000 |
Bid | 0.2050 x 0 |
Ask | 0.2250 x 0 |
Day's Range | 0.2000 - 0.2250 |
52 Week Range | 0.1600 - 0.3000 |
Volume | |
Avg. Volume | 4,008 |
Market Cap | 31.939M |
Beta (5Y Monthly) | -0.51 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0550 |
Earnings Date | Mar 14, 2023 - Mar 20, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Toronto, Ontario – TheNewswire – January 24, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field o...
Toronto, ON - TheNewswire - January 9, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...
Toronto, Ontario – TheNewswire – November 1, 2022 - Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field ...